TITLE

THE RELATIONSHIP BETWEEN METABOLIC SYNDROME AND TARGET ORGAN DAMAGE IN GHANAIAN WITH STAGE-2 HYPERTENSION

AUTHOR(S)
BELLO-RODRIGUEZ, B. M.; SANCHEZ-CRUZ, G.; DELGADO-BUSTILLO, F.; ASIAMA, G.
PUB. DATE
December 2013
SOURCE
Ghana Medical Journal;Dec2013, Vol. 47 Issue 4, p189
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
Objectives: To determine the frequency of Metabolic syndrome (MetS) in stage-2 hypertension and to assess the influence of MetS components over target organ damage (TOD) in Ghanaian patients. Methods: Forty adult patients with stage-2 hypertension were enrolled in a cross-sectional study developed at the Police Hospital, Accra, between 1st February 2009 and 31st January 2010. Diagnosis of MetS was based on The National Cholesterol Education Program in Adult Treatment Panel Revised in 2005 criteria. The alterations on the heart, aortic and carotid arteries, retina, and kidneys were evaluated through the clinical examination including retinal funduscopy, chest X-Ray, ECG, and serum creatinine quantification. The Brain CT-scan was performed on the patients with clinical cerebrovascular disease manifestations. Results: MetS was diagnosed in 25 cases (62.5%); female sex revealed significant association with MetS (OR, 4.88; 95% CI, 1.19-19.94; P=0.027). Ninety-five percent of patients had TOD. Coronary disease was associated with MetS (OR, 4.43; 95% CI, 1.026-19,27; P=0.047) and diabetes mellitus as single MetS component (OR, 14.00; 95% CI, 1.56-125.61; P=0.018). A positive significant correlation was shown of age with cerebrovascular disease (r=0.381; P=0.015) and coronary disease (r=0.623; P=0.000). Non-significant correlation or association (P>0.05) was shown between number of MetS components and number of TOD. Conclusions: In stage-2 hypertension patients a high frequency of MetS with a risk increase in female sex was observed. This stage hypertension is for itself an individual risk to develop cardiovascular disease with high frequency none related with MetS, although coronary disease risk was increased in diabetic patients.
ACCESSION #
94967310

 

Related Articles

  • Type 2 Diabetes Without the Atherogenic Metabolic Triad Does Not Predict Angiographically Assessed Coronary Artery Disease in Women. Blackburn, Patricia; Lemieux, Isabelle; Lamarche, Benoit; Bergeron, Jean; Perron, Patrice; Tremblay, Gérald; Gaudet, Daniel; Després, Jean-Pierre // Diabetes Care;Jan2008, Vol. 31 Issue 1, p170 

    The article focuses on research about the risk of coronary artery disease (CAD) between nondiabetic and type 2 diabetic women with or without features of the atherogenic metabolic triad. It states that physicians may need to go beyond glycemia to appropriately assess or manage CAD risk in their...

  • Fetal origin of vascular aging. Pitale, Shailesh; Sahasrabuddhe, Anagha // Indian Journal of Endocrinology & Metabolism;Oct2011 Supplement, pS289 

    Aging is increasingly regarded as an independent risk factor for development of cardiovascular diseases such as atherosclerosis and hypertension and their complications (e.g. MI and Stroke). It is well known that vascular disease evolve over decades with progressive accumulation of cellular and...

  • Coronary Artery Calcium Screening in Persons with Metabolic Syndrome and Diabetes: Implications for Prevention. Tehrani, David M.; Malik, Shaista; Wong, Nathan D. // Metabolic Syndrome & Related Disorders;Jun2013, Vol. 11 Issue 3, p143 

    Diabetes and metabolic syndrome are major risk factors for coronary heart disease (CHD). Many patients suffering CHD events are not adequately identified by traditional risk assessment, suggesting the need for early detection of subclinical CHD to identify those at highest risk. Coronary artery...

  • Biomarcadores asociados a riesgo de síndrome metabólico: estudio en personal médico y administrativo de la Facultad ¶ de Ciencias de la Salud UNAB - GÉNESIS II. Serrano Díaz, Norma Cecilia; Díaz Martínez, Luis Alfonso; Páez Leal, María Carolina; Colmenares Mejía, Claudia Carolina; Acevedo Rueda, Sandra Milena; Mahecha, Elizabeth Guio; Bautista, Paula Katherine; Martínez Contreras, Luz Ximena; Mora, Gerardo Mantilla // MedUNAB;abr2011, Vol. 14 Issue 1, p40 

    Background: The metabolic syndrome (MS) is a risk factor for coronary heart disease and diabetes mellitus mortality. New cardiovascular risk markers have been proposed with better prognostic ability for taking preventive measures to decrease the occurrence or severity of their consequences....

  • Nontraditional Risk Factors for Coronary Heart Disease Incidence among Persons with Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Saito, Isao; Folsom, Aaron R.; Brancati, Frederick L.; Duncan, Bruce B.; Chambless, Lloyd E.; McGovern, Paul G. // Annals of Internal Medicine;7/18/2000, Vol. 133 Issue 2, p81 

    Examines the association of traditional and nontraditional risk factors with incidence of coronary heart disease in adults with diabetes. Identification of levels of albumin, fibrinogen and von Willebrand factor, factor VIII activity and leukocyte count as predictors of coronary heart disease...

  • Nontraditional Risk Factors for Coronary Heart Disease among Persons with Diabetes. Saito, I.; Folsom, A.R.; Brancati, F.L.; Duncan, B.B.; Chambless, L.E.; McGovern, P.G. // Annals of Internal Medicine;7/18/2000, Vol. 133 Issue 2, pI-16 

    Summarizes a study on nontraditional risk factors for coronary heart disease among persons with diabetes, which appeared in the July 18, 2000 issue of the 'Annals of Internal Medicine.' Association of high fibrinogen levels, high factor VIII levels, high von Willebrand factor levels, high white...

  • Risk Factors for Coronary Heart Disease in Diabetes. Fonseca, Vivian Andrew // Annals of Internal Medicine;7/18/2000, Vol. 133 Issue 2, p154 

    Examines the role of nontraditional risk factors for coronary heart disease in adults with type 2 diabetes. Waste-to-hip ratio; Levels of high-density lipoprotein-3 cholesterol, apolipoproteins A-1 and B, albumin, factor VIII and von Willebrand factor; Leukocyte count; Implications for clinical...

  • Effects of Glimepiride vs Glibenclamide on Ischaemic Heart Disease Risk Factors and Glycaemic Control in Patients with Type 2 Diabetes Mellitus. Britton, M.E.; denver, A.E.; Mohamed-Ali, V.; Yudkin, J.S. // Clinical Drug Investigation;1998, Vol. 16 Issue 4, p303 

    Objective: This study aimed to compare the effects of glimepiride and glibenclamide on glycaemic control and a range of risk factors for ischaemic heart disease (IHD), including concentrations of insulin-like molecules. Patients: A double-blind, placebo-controlled, randomised, crossover...

  • The Diabetic Heart: Too Sweet for Its Own Good? Whittington, Hannah J.; Babu, Girish G.; Mocanu, Mihaela M.; Yellon, Derek M.; Hausenloy, Derek J. // Cardiology Research & Practice;2012, p1 

    Diabetes mellitus is a major risk factor for ischemic heart disease (IHD). Patients with diabetes and IHD experience worse clinical outcomes, suggesting that the diabetic heart may be more susceptible to ischemia-reperfusion injury (IRI). In contrast, the animal data suggests that the diabetic...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics